CC BY-NC-ND 4.0 · South Asian J Cancer
DOI: 10.1055/s-0042-1757551
Original Article

Primary Intraosseous Synovial Sarcoma: Experience from a Tertiary Cancer Center

Vishnu Ramanujan
1   Department of Surgical Oncology, Cancer Institute (WIA), Chennai, Tamil Nadu, India
,
Srikanth Soma
1   Department of Surgical Oncology, Cancer Institute (WIA), Chennai, Tamil Nadu, India
,
Chandra Kumar Krishnan
1   Department of Surgical Oncology, Cancer Institute (WIA), Chennai, Tamil Nadu, India
,
1   Department of Surgical Oncology, Cancer Institute (WIA), Chennai, Tamil Nadu, India
,
2   Department of Medical Oncology, Cancer Institute (WIA), Chennai, Tamil Nadu, India
,
1   Department of Surgical Oncology, Cancer Institute (WIA), Chennai, Tamil Nadu, India
› Author Affiliations

Funding None.

Abstract

Zoom Image
Anand Raja

Introduction Primary intraosseous synovial sarcoma (PISS) is a rare cancer of the bone, with few reported cases across literature. Data from our institute reveals seven indigenous cases. This study aims to evaluate these PISS diagnoses, and to further investigate any histopathological findings and prognostic factors associated with patient survival.

Materials and Methods Data from patients diagnosed with PISS at the institute were obtained from January 1995 to December 2016, in the form of a retrospective study. Patient demographics, pathology locations, histological findings, surgical margins, and treatment modalities were audited as variables that can impact patient survival.

Results This research identified seven cases which fulfilled the diagnostic criteria and were subsequently classified as PISS of the bone. There were five men and two women among the cases, with ages ranging from 16 to 46 years, with a mean of 29.6 years. The study found that the lower limb was the most affected site in PISS, followed by the pelvis. Limb salvage was performed in six patients and one patient underwent amputation. Of these patients, six received adjuvant chemotherapy and four received adjuvant radiation as per institution guidelines. The study found that the 5-year disease-free and overall survival rate was 80 and 61%, respectively.

Conclusion PISS is a rare malignancy with limited cases in literature, and hence, there is no evidence for a standardized management protocol. The survival rates were similar between soft tissue and intraosseous synovial sarcoma among the case series.

Ethical Approval

The study has been approved by the Institutional Ethics Committee of the Cancer Institute, Approval Number: IEC/2020/Nov 10.




Publication History

Article published online:
11 August 2023

© 2022. MedIntel Services Pvt Ltd. This is an open access article published by Thieme under the terms of the Creative Commons Attribution-NonDerivative-NonCommercial License, permitting copying and reproduction so long as the original work is given appropriate credit. Contents may not be used for commercial purposes, or adapted, remixed, transformed or built upon. (https://creativecommons.org/licenses/by-nc-nd/4.0/)

Thieme Medical and Scientific Publishers Pvt. Ltd.
A-12, 2nd Floor, Sector 2, Noida-201301 UP, India

 
  • References

  • 1 Cohen IJ, Issakov J, Avigad S. et al. Synovial sarcoma of bone delineated by spectral karyotyping. Lancet 1997; 350 (9092): 1679-1680
  • 2 Zulkarnaen M, Pan K, Shanmugam P, Ibrahim Z, Chan W. Intraosseous synovial sarcoma of the proximal femur: case report. Malays Orthop J 2012; 6 (01) 49-52
  • 3 Beck SE, Nielsen GP, Raskin KA, Schwab JH. Intraosseous synovial sarcoma of the proximal tibia. Int J Surg Oncol 2011; 2011: 184891
  • 4 Jung SC, Choi JA, Chung JH, Oh JH, Lee JW, Kang HS. Synovial sarcoma of primary bone origin: a rare case in a rare site with atypical features. Skeletal Radiol 2007; 36 (01) 67-71
  • 5 Wu X, Popovic M, Chow E, Zhang X. Primary synovial sarcoma of the distal femur: a rare case report. J Pain Manag 2014; 1 (07) 95-98
  • 6 van Vliet M, Kliffen M, Krestin GP, van Dijke CF. Soft tissue sarcomas at a glance: clinical, histological, and MR imaging features of malignant extremity soft tissue tumors. Eur Radiol 2009; 19 (06) 1499-1511
  • 7 Haldar M, Randall RL, Capecchi MR. Synovial sarcoma: from genetics to genetic-based animal modeling. Clin Orthop Relat Res 2008; 466 (09) 2156-2167
  • 8 Jeganathan R, Davis R, Wilson L, McGuigan J, Sidhu P. Primary mediastinal synovial sarcoma. Ulster Med J 2007; 76 (02) 109-111
  • 9 Hiraga H, Nojima T, Isu K, Yamashiro K, Yamawaki S, Nagashima K. Histological and molecular evidence of synovial sarcoma of bone. A case report. J Bone Joint Surg Am 1999; 81 (04) 558-563
  • 10 O'Donnell P, Diss TC, Whelan J, Flanagan AM. Synovial sarcoma with radiological appearances of primitive neuroectodermal tumour/Ewing sarcoma: differentiation by molecular genetic studies. Skeletal Radiol 2006; 35 (04) 233-239
  • 11 McHugh KE, Reith JD, Mesko NW, Kilpatrick SE. Primary intraosseous synovial sarcoma with molecular confirmation: expanding and clarifying the spectrum of this rare neoplasm. Case Rep Pathol 2020; 2020: 5492754
  • 12 Nakajo M, Ohkubo K, Nandate T. et al. Primary synovial sarcoma of the sternum: computed tomography and magnetic resonance imaging findings. Radiat Med 2005; 23 (03) 208-212
  • 13 Sar C, Eralp L. Surgical treatment of primary tumors of the sacrum. Arch Orthop Trauma Surg 2002; 122 (03) 148-155
  • 14 Scully SP, Temple HT, Harrelson JM. Synovial sarcoma of the foot and ankle. Clin Orthop Relat Res 1999; (364) 220-226
  • 15 Tilakaratne WM. Synovial sarcoma of the mandible. J Oral Pathol Med 2006; 35 (01) 61-63
  • 16 Cao Y, Jiang C, Chen Z, Jiang X. A rare synovial sarcoma of the spine in the thoracic vertebral body. Eur Spine J 2014 May;23 Suppl 2:228-35. doi: 10.1007/s00586-013-3099-4. PMID: 24232695
  • 17 Campbell C, Gallagher J, Dickinson I. Synovial sarcoma–towards a simplified approach to prognosis. ANZ J Surg 2004; 74 (09) 727-731